Abstract:Neuronal cell death is a prominent pathological feature of AD and the best correlate of cognitive impairment and dementia, followed by neurofibrillary tau (NFT) pathology. Although the precise molecular events of tau-mediated neuronal loss in AD are poorly understood, pathways involving tau cleavage by active caspases (aCasps) and defective autophagy-mediated clearance of toxic tau species are shown to significant induce neuronal loss in AD. We recently showed a correlation between aCasp-6 and macroautophagy, NFT burden, and neuronal loss, in human brainstem nuclei showing the earliest vulnerability to NFT accumulation (Theofilas et al. 2018). Here, we further probe the interplay between aCasps, autophagy/lysosome system and tau pathology in a mechanistic study using iPSC-derived cortical neurons with the MAPT V337M variant that causes pathological tau accumulation similar to human AD, and isogenic controls cultured for up to 12 weeks. Multiplex IF and western blot analyses showed early positivity for cortical, neuronal and aCasp6 markers as early as 4-week cultured neurons (Fig. 1 A-C) and a time-dependent upregulation of Casp-cleaved Tau (Tau C3), oligomeric tau/ p-tau and the macro-autophagy markers LC3 and p62 in the mutant line (Fig. 1 D). Differences between tau PTM levels in mutant and controls manifested only after 8 weeks, probably due to elevated tau levels associated to development in younger neurons. Multiplex IF and western blot analysis were used to investigate the presence of aCasp6 positivity, Tau C3, oligomeric tau and macro-autophagy markers in iPSC-derived neurons that model the molecular basis of tau pathogenesis. Comparing tau, Tau C3 and macro-autophagy levels between control and V337M lines, we detected a time-dependent upregulation of the protein markers in 12-week cultured V337M neurons relative to controls.

Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease

Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease

Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation

Activity-dependent Tau Cleavage by Caspase-3 Promotes Neuronal Dysfunction and Synaptotoxicity.

Caspase-3 cleaved tau impairs mitochondrial function through the opening of the mitochondrial permeability transition pore

Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

NLRP3 inflammasome activation drives tau pathology

Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration

Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain

Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting

Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation

β-Secretase 1’s Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice

Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10: A MECHANISM INVOLVED IN TAU PATHOLOGY OF ALZHEIMER DISEASE

β2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models

Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease

GSK3 and p53 - is there a link in Alzheimer's disease?

P3‐200: TAU‐MEDIATED CELL DEATH MECHANISMS IN MAPT V337M IPSC‐DERIVED HUMAN NEURONS

Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway